Is Xtandi a form of chemotherapy?

XTANDI is an androgen receptor inhibitor; it is not a chemotherapy. Androgens are a group of hormones that includes testosterone. Androgen receptor inhibitors interfere with the connection between androgens and androgen receptors. This can help slow cancer cell growth.

Table of Contents

What is the medication Xtandi used for?

XTANDI is a prescription medicine used to treat men with prostate cancer that no longer responds to a hormone therapy or surgical treatment to lower testosterone OR has spread to other parts of the body and responds to a hormone therapy or surgical treatment to lower testosterone.

How long do people take Xtandi?

Median treatment duration was 40.2 months in the Xtandi group, just about 14 months on placebo and nearly 24 months in a group that had crossed over from placebo to Xtandi. About 34.5%, or 397 patients, remained on the treatment at the May 28 cutoff point with a median follow-up of nearly 45 months.

Can Xtandi cure cancer?

Xtandi (enzalutamide) is a hormone therapy used to treat advanced prostate cancer. It doesn’t cure prostate cancer, but can control it by slowing the progression and spread of the disease – often for several years.

What is the average cost of Xtandi?

Xtandi (enzalutamide), which is co-licenced by Japan’s Astellas Pharma and Pfizer, costs US patients about $156,000 a year on average – five times more than it costs in Japan and Canada, according to Knowledge Ecology International, which is champining the new appeal.

Does Xtandi cause memory loss?

Other side effects include: lower respiratory tract infection, pneumonia, pulmonary infection, altered mental status, amnesia, bronchitis, cognitive dysfunction, falling, hypertension, hypoesthesia, and memory impairment.

Does Xtandi reduce PSA?

During clinical trials, researchers count the number of men whose PSA levels reduce by 50 percent or more following the initiation of treatment with Xtandi. This is one of the ways in which they assess how well Xtandi is working. Prostate Cancer Foundation. The PSA Test.

What is the life expectancy for stage 4 prostate cancer?

When prostate cancer reaches stage 4 and has spread (metastasized) to other organs such as the lungs, liver, or bones, the five-year survival rate falls below 30%. At stage 4, prostate cancer is unlikely to be cured, although with effective therapy, many people can live for several years.

Can you live 10 years with metastatic prostate cancer?

Of the 794 evaluable patients, 77% lived < 5 years, 16% lived 5 up to 10 years, and 7% lived > or = 10 years. Factors predicting a statistical significant association with longer survival (P < 0.05) included minimal disease, better PS, no bone pain, lower Gleason score, and lower PSA level.

Does Medicare cover the drug Xtandi?

Do Medicare prescription drug plans cover Xtandi? Yes. 100% of Medicare prescription drug plans cover this drug.

Can Xtandi cause memory loss?

Does Xtandi affect the heart?

Blockage of the arteries in the heart (ischemic heart disease) that can lead to death has happened in some people during treatment with XTANDI. Your doctor will monitor you for signs and symptoms of heart problems during your treatment.

How successful is Xtandi?

At 12 months, 65% of the Xtandi patients had no disease progression. Only 14% of the placebo group was without progression. At the conclusion of data collection, 72% of the Xtandi patients were still alive, compared to 63% in the placebo group. The rate of adverse events with the two groups was comparable.

How long can you live when prostate cancer spreads to bones?

Findings from one 2017 study estimated that in those with prostate cancer that spreads to the bones: 35 percent have a 1-year survival rate. 12 percent have a 3-year survival rate. 6 percent have a 5-year survival rate.

What is the life expectancy of someone with stage 4 prostate cancer?

Stage-4 Prostate Cancer (IV)

This is the last stage of prostate cancer and describes a tumor that has spread to other parts of the body, including the lymph nodes, lungs, liver, bones, or bladder. For these cancers, the 5-year survival rate is 29%.

Is Xtandi a form of chemotherapy?